
|
Report Date : |
29th
December, 2006 |
IDENTIFICATION
DETAILS
|
Name : |
APOTECNIA
SA |
|
|
|
|
Registered Office : |
Carretera
De Zeneta N 149, 30858 Totana (Murcia) |
|
|
|
|
Country : |
Spain |
|
|
|
|
Financials (as on) : |
31.12.2005 |
|
|
|
|
Date of Incorporation : |
09/03/1984 |
|
|
|
|
Legal Form : |
Joint
Stock Company |
|
|
|
|
Line of Business : |
Manufacture
of basic pharmaceutical products |
RATING & COMMENTS
|
MIRA’s Rating : |
Aa |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
71-85 |
Aa |
Possesses adequate working capital. No
caution needed for credit transaction. It has above average (strong)
capability for payment of interest and principal sums |
Large |
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
APOTECNIA SA
A28913283
COMPANY
SITUATION: REACTIVATION OF THE
COMPANY
Tax
Number A28913283
NAME APOTECNIA
SA
BUSINESS
ADDRESS CARRETERA DE
ZENETA N 149
Postcode 30858
TOTANA (MURCIA)
FORMER
ADDRESS POLIGONO
INDUSTRIAL SILVOTA, 22
Postcode 33420
POSADA (ASTURIAS (OVIEDO))
TELEPHONE 968368303
FAX 968854361
LEGAL
FORM JOINT STOCK
COMPANY
DATE
FOUNDED 09/03/1984
CAPITAL 120.202,42 Euros
PAID-UP
CAPITAL 120.202,42 Euros
NUMBER
OF EMPLOYEES 50
ACTIVITY 1254100 - Mfg.
of basic pharmaceutical products
CNAE 2441 - Manufacture
of basic pharmaceutical products
EXPORT
COMPANY YES
IMPORT
COMPANY YES
FINANCIAL SITUATION (Year
ending: 31/12/2005)
![]()
TREASURY
9/9 Excellent
DEBT
9/9 Nil
INCIDENTS
![]()
COMMITMENTS
9/9 Respected
INCIDENTS
9/9 None
or Negligible
PREVIOUS EXPERIENCE
![]()
PREVIOUS
EXPERIENCE
7/9 Normal
CREDIT ACCORDING TO OBJECTIVE
DATA (From 0 to 500.000,00 Euros):
FAVOURABLE
TOWARDS 14.424,29 Max. Euros
SOLVENCY RATING:
14/20 (BASED ON HOMOGENEOUS
FORMULATION)

Analysis made on 22/11/2006
Figures given in Euros
|
|
Balance sheet 2.003 (12) |
Balance sheet 2.004 (12) |
Balance sheet 2.005 (12) |
|
|
ADDED VALUE |
-644,03 |
-110,66 |
-108,99 |
|
|
BUSINESS RESULT |
-2.587,07 |
821,73 |
-68,75 |
|
|
OWN FUNDS |
115.259,78 |
116.081,51 |
116.012,76 |
|
|
DEBT |
25.297,80 |
25.267,40 |
25.266,15 |
|
|
TOTAL ASSET |
140.557,58 |
141.348,91 |
141.278,91 |
|
|
|
|
|||
Added value grew by
1,51% compared with the previous year. Shareholders equity are
116.012,76 Euros for an indebtedness of 25.266,15
Euros .
The result -68,75
Euros means financial profitability of -0,06% and
economic profitability of -0,05% . This result means growth of
-108,37% compared with the 2.004 .
THE FIGURES FOR THE LAST BALANCE
SHEET ARE RELEVANT:
SOURCE: FROM THE MERCANTILE
REGISTER
DATE: 31/10/2006
|
|
Company |
Sector |
Difference |
|
|
(2.005) |
|
|
|
% of PRODUCTION VALUE |
|
|
|
|
SALES |
|
99,05 |
-99,05 |
|
ADDED
VALUE |
|
35,40 |
-35,40 |
|
BUSINESS
RESULT |
|
4,65 |
-4,65 |
|
% OF TOTAL ASSETS |
|
|
|
|
OWN
FUNDS |
82,12 |
56,35 |
25,77 |
|
DEBT |
17,88 |
43,65 |
-25,77 |
Compared sector (CNAE): 244 - Fabricación de productos
farmacéuticos
Number of companies: 22
Size (Sales Figure): 2.800.000,00 - 7.000.000,00 Euros
The company’s own resources are 82,12%
, 25,77% above the mean for the sector.
The company’s outside resources are
17,88% , 25,77% below the mean for the sector.
No legal incidences registered
for this company in the official source
No claims registered for this
company in the official sources
AFFECTED BY: No significant
elemento
|
Position |
Surname and name |
Date of appointment |
|
SOLE ADMINISTRATOR |
ARIAS AGUILAR GERARDO UBALDO |
19/02/2003 |
|
Shareholders |
||||
|
Company Name |
CIF/Country |
|
Source |
Information Date |
|
ASTURPHARMA SA |
A33070988 |
100,00% |
OWN SOURCES |
09/10/2006 |
|
Proceedings |
Date |
Notice Num. |
Mercantile Reg. |
|
Registration of accounts
(2005) |
21/11/2006 |
912069 |
MURCIA |
|
Change of adress |
29/09/2006 |
474105 |
MURCIA |
|
Appointments |
15/02/2006 |
081599 |
ASTURIAS (OVIEDO) |
|
Registration of accounts
(2004) |
08/02/2006 |
056142 |
ASTURIAS (OVIEDO) |
|
Registration of accounts
(2003) |
25/08/2004 |
246111 |
ASTURIAS (OVIEDO) |
22/06/2006 LA
NUEVA ESPANA LEGAL ANNOUNCE
LA JUNTA GRAL. UNIVERSAL DE ESTA SDAD.
CELEBRADA EL DIA 10/03/06 ACORDO POR UNANIMIDAD TRASLADAR EL DOMICILIO SOCIAL A
LA CARRETERA DE ZENETA, N. 149, EL RAIGUERO, LA VILLA, BENIEL (MURCIA).
26/01/2006 LA
NUEVA ESPANA GENERAL
INFORMATION
EL GRUPO INDUSTRIAL FARMACEUTICO ASTURPHARMA
HA ADQUIRIDO UNA PLANTA DE FA BRICACION EN ZENETA (MURCIA), HASTA AHORA
PROPIEDAD DE LOS LABORATORIOS ITA LIANOS RECORDATI. LA OPERACION, POR UN
IMPORTE DE 13 MM. DE EUROS, HA SIDO ACOMETIDA POR APOTECNIA, UNA SDAD. DEL
GRUPO ASTURPHARMA. LA ADQUISICION DE LA PLANTA MURCIANA DE RECORDATI PERMITIRA
AL GRUPO ASTURPHARMA AMPLIAR SU GAMA DE PRODUCTOS. LA INVERSION DE APOTECNIA EN
MURCIA INCLUYE LA ADQUISI CION TANTO DE LOS ACTIVOS MATERIALES COMO DE LAS
PATENTES DE FABRICACION QUE RECORDATI VENIA PRODUCIENDO EN SU FABRICA ESPAŃOLA.
01/03/06 BLOQUE DE INVESTIGACION:
- Actividad: planta de principios
activos farmaceuticos.
- Domicilio Social: Pol. Ind.
Silvota, 22 Posada (33424) ASTURIAS.
oficina en zona industrial.
- El total de socios asciende a
1.
- Realiza transacciones
intracomunitarias de sus ventas y compras con
todo el mundo.
----------------------------------------------------------------------
El bloque de Investigacion no
esta sujeto a actualizaciones sistemati-
cas. Los datos mostrados fueron
aportados por las fuentes consultadas
en la fecha del encabezamiento.
The information on the last account
contained in this report is extracted from the Mercantile Register file of the
legal address of the Company and dated 31/10/2006
|
(Figures given in Euros) |
31/12/2003 (12) |
31/12/2004 (12) |
31/12/2005 (12) |
|
|
|
A) DUE FROM SHAREHOLDERS FOR UNCALLED
CAPITAL |
|
|
|
|
|
B) FIXED ASSETS |
|
|
|
|
|
I. Establishment expenses |
|
|
|
|
|
II. Intangible assets |
|
|
|
|
|
III. Tangible assets |
|
|
|
|
|
IV. Financial assets |
|
|
|
|
|
V. Owners equity |
|
|
|
|
|
VI. Long term trade liabilities |
|
|
|
|
|
C) DEFERRED EXPENSES |
|
|
|
|
|
D) CURRENT ASSETS |
140.557,58 |
141.348,91 |
141.278,91 |
|
|
I. Not paid in shareholder capital |
|
|
|
|
|
II. Inventory |
|
|
|
|
|
III. Debtors |
137.385,86 |
138.329,55 |
38.379,53 |
|
|
IV. Short term financial assets |
59,46 |
59,58 |
100.052,68 |
|
|
V. Short term owners equity |
|
|
|
|
|
VI. Cash |
3.112,26 |
2.959,78 |
2.846,70 |
|
|
VII. Prepaid expenses and accrued income |
|
|
|
|
|
ASSETS (A + B + C + D) |
140.557,58 |
141.348,91 |
141.278,91 |
|
(Figures given in Euros) |
31/12/2003 (12) |
31/12/2004 (12) |
31/12/2005 (12) |
|
|
|
A) SHAREHOLDERS EQUITY |
115.259,78 |
116.081,51 |
116.012,76 |
|
|
I. Capital |
120.202,42 |
120.202,42 |
120.202,42 |
|
|
II. Premium share account |
|
|
|
|
|
III. Revaluation reserve |
|
|
|
|
|
IV. Reserves |
|
|
|
|
|
V. Prior year earnings |
-2.355,57 |
-4.942,64 |
-4.120,91 |
|
|
VI. Prior year profit or losses |
-2.587,07 |
821,73 |
-68,75 |
|
|
VII. Dividend paid during the year |
|
|
|
|
|
VIII. Own shares for change in capital |
|
|
|
|
|
B) DEFERRED INCOME |
|
|
|
|
|
C) PROVISIONS FOR LIABILITIES AND EXPENSES |
|
|
|
|
|
D) LONG TERM LIABILITIES |
22.754,32 |
22.754,32 |
22.754,32 |
|
|
E) SHORT TERM LIABILITIES |
2.543,48 |
2.513,08 |
2.511,83 |
|
|
F) SHORT TERM PROVISIONS FOR LIABILITIES
AND EXPENSES |
|
|
|
|
|
LIABILITIES (A + B + C + D + E + F) |
140.557,58 |
141.348,91 |
141.278,91 |
|
(Figures given in Euros) |
31/12/2003 (12) |
31/12/2004 (12) |
31/12/2005 (12) |
|
|
|
A) EXPENSES (A.1 a A.15) |
|
|
|
|
|
A.1 Operating Expenses |
|
|
|
|
|
A.3. Labor cost |
|
|
|
|
|
A.3. Assets depreciation |
|
|
|
|
|
A.4. Variance in provision for current
assets |
|
|
|
|
|
A.5. Other operating costs |
644,03 |
110,66 |
108,99 |
|
|
A.I. OPERATING RESULT
(B.1-A.1-A.2-A.3-A.4-A.5) |
|
|
|
|
|
A.6. Financial expenses |
|
|
|
|
|
A.7. Variation in financial investments
provision |
|
|
|
|
|
A.8. Exchange losses |
|
|
|
|
|
A.II. POSITIVE FINANCIAL RESULTS
(B.2+B.3-A.6-A.7-A.8) |
|
|
|
|
|
A.III. PROFIT FROM ORDINARY ACTIVITIES
(A.I+A.II-B.I-B.II) |
|
|
|
|
|
A.9. Variation in provision in fixed
assets |
|
|
|
|
|
A.10. Losses in fixed assets |
|
|
|
|
|
A.11. Losses from shares and bonds |
|
|
|
|
|
A.12. Extraordinary charges |
|
|
|
|
|
A.13. Prior year’s expenses and losses |
2.133,35 |
|
0,03 |
|
|
A.IV. POSITIVE EXTRAORDINARY RESULT
(B.4+B.5+B.6+B.7+B.8-A.9-A.10-A.11-A.12-A.13) |
|
|
3,22 |
|
|
A.V. EARNINGS / LOSS BEFORE TAXES
(A.III+A.IV-B.III-B.IV) |
|
|
|
|
|
A.14. Corporate Taxes |
33,75 |
-932,39 |
-37,02 |
|
|
A.15. Other taxes |
|
|
|
|
|
A.VI. YEAR END RESULT (PROFIT)
(A.V-A.14-A.15) |
|
821,73 |
|
|
|
B) INCOMES (B.1 a B.8) |
|
|
|
|
|
B.1. Operating income |
|
|
|
|
|
B.I. OPERATING LOSSES
(A.1+A.2+A.3+A.4+A.5-B.1) |
644,03 |
110,66 |
108,99 |
|
|
B.2. Financial Income |
|
|
|
|
|
B.3. Gains on exchange |
|
|
|
|
|
B.II. FINANCIAL LOSSES
(A.6+A.7+A.8-B.2-B.3) |
|
|
|
|
|
B.III. LOSSES FROM ORDINARY ACTIVITIES
(B.I+B.II-A.I-A.II) |
644,03 |
110,66 |
108,99 |
|
|
B.4. Gains from disposal of fixed assets |
|
|
|
|
|
B.5. Gains from dealing in own shares |
|
|
|
|
|
B.6. Paid in surplus |
|
|
|
|
|
B.7. Extraordinary income |
224,06 |
|
|
|
|
B.8. Prior year’s income and profits |
|
|
3,25 |
|
|
B.IV. EXTRAORDINARY LOSSES
(A.9+A.10+A.11+A.12+A.13-B.4-B.5-B.6-B.7-B.8) |
1.909,29 |
|
|
|
|
B.V. LOSS BEFORE TAXES
(B.III+B.IV-A.III-A.IV) |
2.553,32 |
110,66 |
105,77 |
|
|
B.VI. NET LOSS (B.V+A.14+A.15) |
2.587,07 |
|
68,75 |
|
(Figures given in Euros) |
2.003 (12) |
2.004 (12) |
2.005 (12) |
|
|
|
ACTIVITY |
|
|
|
|
|
Increase of the Sales Figures |
|
|
|
|
|
Assets Turnover |
|
|
|
|
|
Productivity |
|
|
|
|
|
Increase of the Added Value |
71,45 |
82,82 |
1,51 |
|
|
PROFITABILITY |
|
|
|
|
|
Economic Profitability |
-1,84 |
0,58 |
-0,05 |
|
|
Financial Profitability |
-2,24 |
0,71 |
-0,06 |
|
|
Financial Expenses |
|
|
|
|
|
BALANCE (IN DAYS OF SALES) |
|
|
|
|
|
Customers’ Credit (In days of sales) |
|
|
|
|
|
Suppliers’ Credit (In days of sales) |
|
|
|
|
|
Working Capital (In days of sales) |
|
|
|
|
|
Working Capital Requirement (In days of
sales) |
|
|
|
|
|
Treasury (In days of sales) |
|
|
|
|
|
BALANCE |
|
|
|
|
|
Working Capital |
138.014,10 |
138.835,83 |
138.767,08 |
|
|
Working Capital Requirement |
134.842,38 |
135.816,47 |
35.867,70 |
|
|
Treasury |
3.171,72 |
3.019,36 |
102.899,38 |
|
|
Balance Ratio |
|
|
|
|
|
SOLVENCY |
|
|
|
|
|
Borrowing Ratio |
18,00 |
17,88 |
17,88 |
|
|
Own / Permanent Funds |
83,51 |
83,61 |
83,60 |
|
|
Payback Capacity |
|
|
|
|
|
LIQUIDITY |
|
|
|
|
|
General Liquidity |
55,26 |
56,25 |
56,25 |
|
|
Immediate Liquidity |
1,25 |
1,20 |
40,97 |
|
(Figures given in Percentages) |
Company |
Sector |
Company |
|
|
2.005 |
|
|
|
Assets |
|||
|
DUE FROM SHAREHOLDERS
FOR UNCALLED CAPITAL |
0,00 |
0,00 |
0,00 |
|
FIXED ASSETS |
0,00 |
41,19 |
-41,19 |
|
ACCRUED EXPENSES |
0,00 |
0,34 |
-0,34 |
|
CURRENT ASSETS |
100,00 |
58,47 |
41,53 |
|
TOTAL ASSETS |
100,00 |
100,00 |
0,00 |
|
Liabilities |
|||
|
SHAREHOLDERS EQUITY |
82,12 |
56,35 |
25,77 |
|
ACCRUED INCOME |
0,00 |
0,20 |
-0,20 |
|
RISK AND EXPENDITURE
COVER |
0,00 |
0,00 |
0,00 |
|
LONG-TERM CREDITORS |
16,11 |
8,33 |
7,78 |
|
SHORT-TERM CREDITORS |
1,78 |
35,12 |
-33,34 |
|
SHORT-TERM RISK AND
EXPENDITURE COVER |
0,00 |
0,00 |
0,00 |
|
TOTAL LIABILITIES |
100,00 |
100,00 |
0,00 |
|
(Figures given in ) |
Company |
Ptile25 |
Medium |
Ptile75 |
|
|
2.005 |
|
|
|
|
ACTIVITY |
|
|
|
|
|
Increase of the Sales
Figures |
|
-10,46 |
-0,08 |
12,88 |
|
Assets Turnover |
|
0,84 |
1,14 |
2,18 |
|
Fixed Assets Turnover |
|
1,73 |
3,44 |
9,04 |
|
Increase of the Added
Value |
1,51 |
-5,49 |
2,16 |
25,99 |
|
PRODUCTIVITY |
|
|
|
|
|
Productivity |
|
1,24 |
1,53 |
1,84 |
|
Change of Personnel
Costs |
|
-5,13 |
8,57 |
16,42 |
|
Average Personnel Costs |
|
25.127,23 |
29.434,94 |
34.620,70 |
|
Value Added by Employees |
|
33.831,91 |
48.658,68 |
51.819,81 |
|
CASH FLOW |
|
|
|
|
|
Cash Flow |
-68,75 |
141.079,72 |
302.460,30 |
481.357,54 |
|
Operating Cash Flow |
-108,99 |
184.807,88 |
333.778,80 |
665.961,26 |
|
Change in Cash Flow |
-108,37 |
-19,95 |
13,50 |
33,11 |
|
PROFITABILITY |
|
|
|
|
|
Economic Profitability |
-0,05 |
1,83 |
4,04 |
8,63 |
|
Financial Profitability |
-0,06 |
3,80 |
8,89 |
17,02 |
|
Financial Expenses |
|
0,28 |
0,71 |
1,75 |
|
Gross Economic
Profitability |
-0,08 |
7,46 |
10,97 |
17,13 |
|
Gross Financial
Profitability |
-0,09 |
13,38 |
24,17 |
39,93 |
|
BALANCE (IN DAYS OF SALES) |
|
|
|
|
|
Customers’ Credit (In
days of sales) |
|
54,16 |
86,29 |
109,36 |
|
Suppliers’ Credit (In
days of sales) |
|
0,00 |
0,00 |
79,72 |
|
Working Capital (In days
of sales) |
|
6,23 |
42,23 |
118,42 |
|
Working Capital
Requirement (In days of sales) |
|
-7,42 |
32,83 |
69,28 |
|
Treasury (In days of
sales) |
|
0,88 |
16,70 |
37,83 |
|
Operating Current Assets |
|
112,38 |
148,01 |
286,08 |
|
BALANCE |
|
|
|
|
|
Working Capital |
138.767,08 |
64.204,17 |
637.229,85 |
1.290.019,99 |
|
Working Capital
Requirement |
35.867,70 |
-79.167,56 |
329.104,20 |
765.050,93 |
|
Treasury |
102.899,38 |
8.607,61 |
157.325,09 |
403.981,71 |
|
Balance Ratio |
|
1,07 |
1,40 |
3,69 |
|
SOLVENCY |
|
|
|
|
|
Borrowing Ratio |
17,88 |
36,90 |
50,94 |
68,26 |
|
Own / Permanent Funds |
83,60 |
79,59 |
93,37 |
99,13 |
|
Payback Capacity |
|
0,20 |
0,34 |
0,41 |
|
Long term Indebtedness |
16,11 |
0,41 |
2,48 |
13,87 |
|
Gearing |
121,78 |
158,47 |
205,09 |
315,13 |
|
Financing Basic Ratio |
1,00 |
1,00 |
1,00 |
1,00 |
|
Assets Guarantee |
5,59 |
1,26 |
1,65 |
2,68 |
|
LIQUIDITY |
|
|
|
|
|
General Liquidity |
56,24 |
1,05 |
1,35 |
2,38 |
|
Immediate Liquidity |
40,97 |
0,05 |
0,31 |
0,59 |
The date when this report was
last updated is 22/11/2006.
This company was last
displayed on 29/12/2006,
it has been
viewed 30 times in the last quarter and 149 times in
total .
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial
base with the strongest capability for timely payment of interest and
principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No
caution needed for credit transaction. It has above average (strong)
capability for payment of interest and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are
regarded healthy. General unfavourable factors will not cause fatal effect.
Satisfactory capability for payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal.
Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors
carry similar weight in credit consideration. Capability to overcome financial
difficulties seems comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of
interest and principal sums in default or expected to be in default upon
maturity |
Limited with full security |
|
<10 |
C |
Absolute credit risk exists. Caution
needed to be exercised |
Credit not recommended |
|
NR |
In view of the lack of information, we
have no basis upon which to recommend credit dealings |
No Rating |
|